Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
ICYMI-The Leukemia & Lymphoma Society (LLS) is now Blood Most cancers United, and we're elevating consciousness throughout Blood Most cancers Consciousness Month...
For John Frotton, a 66-year-old chemical engineer from East Stroudsburg, Pennsylvania, numbers are a lifestyle. He spends his days engaged on advanced...
HIGH POINT, NC (September 11, 2025) LiveLung, a 501(c)(3) nonprofit group devoted to supporting lung most cancers sufferers, survivors, and their care...
